T.TH
|
Good ol' Doug Loe, the most conservative Analyst on the street in...
|
T.TH
|
"Patients who were started on Trogarzo and Egrifta in 2019 40 percent...
|
T.TH
|
The Q3 MD&A said it was progressing as planned, so nothing at that point....
|
T.TH
|
I find that my theories are getting wilder by the day and I need a tinfoil...
|
T.TH
|
I know. That is complete BS in my opinion. I just read the MD&A and the...
|
T.TH
|
Overall it was a healthy call. Management put on a good show in the face of...
|
T.TH
|
I was about to say the same thing... no financials or MD&A.
|
T.TH
|
Again though, a C-Suite Exec should know better than to post about things...
|
T.TH
|
The only other possibility I can think of is layoffs are occurring today...
|
T.TH
|
This thought did cross my mind. However, if that were the case and TH were...
|
T.TH
|
I posted a couple screen shots over on StockTwits. More tea leaves perhaps...
|
T.TH
|
"Hey, we want to buy/partner with your company, but we need a little bit...
|
T.TH
|
They are refocusing the business, but still need a robust pipeline. I my read...
|
T.TH
|
Perhaps they pulled out of the Pliant deal because they are in talks with a...
|
T.TH
|
Does someone with more brains than me take a deeper look at Novartis. They...
|
T.TH
|
I went creeping through TH's linkedin posts to see who was liking...
|
T.TH
|
If you have followed TH for a while you will notice that buyers don't...
|
T.TH
|
The AH trades on NASDAQ seemed to like the CROI news. Obviously volume was...
|
T.TH
|
Good find. When was this published?
|
T.TH
|
I would have to agree. The PR last week was to communicate the can kicking...
|